About Enhancer
| Enhancer ID: | E_00272 |
| Species: | Homo sapiens |
| Position : | chr3:111274086-111275786   |
| Year: | 2025 |
| Title: | Enhancer activation from transposable elements in extrachromosomal DNA |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | chronic myeloid leukemia |
| PMID: | 41120733 |
| MONDO: | MONDO:0011998 |
| Tissue: | Blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | K562 |
| CVCL ID: | CVCL_0004 |
| Cell Type: | chronic myeloid leukemia cell |
| Cell Ontology ID: | CL:0001054 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay |
| High Throughput Method: | Hi-C, ATAC-seq |
| Low Throughput Method: | Luciferase reporter assay, CRISPR knockout, CRISPRi, ORCA |
About Target Gene
| Target gene : | MYC |
About TF
| TF name : |
About Regulatory State
| Regulatory State : | Active |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer Associated Network
Expression of Target Genes for the Enhancer